Most Popular
-
1
Now is no time to add pressure on businesses: top executives
-
2
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
3
Seoul to host winter festival from Dec. 13
-
4
Blackpink's solo journeys: Complementary paths, not competition
-
5
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
6
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
7
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
8
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
9
Actor Song Joong-ki welcomes second child in Rome
-
10
Main opposition pushes to ease, not postpone, tax on crypto gains
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
[THE INVESTOR] Ildong Pharmaceutical’s Hepatitis B treatment Besifovir is in the process of receiving the Ministry of Food and Drug Safety’s approval for sales, according to industry sources on Sept. 26.
It will be the first new drug to be developed by the South Korea pharmaceutical company, to be introduced next year.
Besifovir has completed phase 3 of clinical trials that found it to be as effective as Gilead Science’s Viread, which sold more than 100 billion won (US$90.63 million) worldwide in 2015.
It will be the first new drug to be developed by the South Korea pharmaceutical company, to be introduced next year.
Besifovir has completed phase 3 of clinical trials that found it to be as effective as Gilead Science’s Viread, which sold more than 100 billion won (US$90.63 million) worldwide in 2015.
Originally developed by LG Life Sciences which sold the rights to Ildong after completing the second phase clinical trials in 2012, Besifovir was also found to be equally effective as BMS Pharmaceutical’s Baraclude, another big selling drug that generated over 100 billion won last year.
Ildong Pharmaceutical is one of the country’s top 10 pharmaceutical companies and posted 470 billion won in sales last year.
By Hwang You-mee (glamazon@heraldcorp.com)
![[Today’s K-pop] Babymonster logs 100m views with ‘Drip’ music video](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/11/22/20241122050051_0.jpg&u=20241122172213)